selected scholarly activity
-
journal articles
- Phage-Antibiotic Combinations for Pseudomonas: Successes in the Clinic and In Vitro Tenuously Connected.. Microbial Biotechnology. 18:e70193. 2025
- Re-evaluating what makes a phage unsuitable for therapy.. npj Antimicrobials and Resistance. 3:45. 2025
- Temperate phage-antibiotic synergy is widespread-extending to Pseudomonas-but varies by phage, host strain, and antibiotic pairing.. mBio. 16:e0255924. 2025
- Temperate phage-antibiotic synergy across antibiotic classes reveals new mechanism for preventing lysogeny. mBio. 15:e0050424. 2024
- Phage Therapy in the Management of Urinary Tract Infections: A Comprehensive Systematic Review. PHAGE: Therapy, Applications, and Research. 4:112-127. 2023
- Correction: Sutcliffe et al. Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut. Viruses 2021, 13, 455. Viruses. 15:25-25. 2022
- Efficacy of Salmonella Bacteriophage S1 Delivered and Released by Alginate Beads in a Chicken Model of Infection. Viruses. 13:1932-1932. 2021
- Temperate phage-antibiotic synergy eradicates bacteria through depletion of lysogens. Cell Reports. 35:109172-109172. 2021
- Does over a century of aerobic phage work provide a solid framework for the study of phages in the gut?. Anaerobe. 68:102319-102319. 2021
- Common Oral Medications Lead to Prophage Induction in Bacterial Isolates from the Human Gut. Viruses. 13:455-455. 2021
- Bacterial membrane vesicles and phages in blood after consumption ofLacticaseibacillus rhamnosusJB-1. Gut Microbes. 13:1993583. 2021
- In the Anti-CRISPR Jungle, Only the Weak Thrive?. Cell Host and Microbe. 27:157-159. 2020
- Widespread anti-CRISPR proteins in virulent bacteriophages inhibit a range of Cas9 proteins. Nature Communications. 9:2919. 2018
- An anti-CRISPR from a virulent streptococcal phage inhibits Streptococcus pyogenes Cas9. Nature Microbiology. 2:1374-1380. 2017
- Detecting natural adaptation of the Streptococcus thermophilus CRISPR-Cas systems in research and classroom settings. Nature Protocols. 12:547-565. 2017
- Phagebook: The Social Network. Molecular Cell. 65:963-964. 2017
- Applications of CRISPR-Cas in its natural habitat. Current Opinion in Chemical Biology. 34:30-36. 2016
- Functional and Evolutionary Characterization of a Gene Transfer Agent’s Multilocus “Genome”. Molecular Biology and Evolution (MBE). 33:2530-2543. 2016
- Programming Native CRISPR Arrays for the Generation of Targeted Immunity. mBio. 7:e00202-e00216. 2016
- Adaptation in bacterial CRISPR-Cas immunity can be driven by defective phages. Nature Communications. 5:4399. 2014
- CRISPR-Cas Systems: Making the Cut. Microbe. 9:204-210. 2014
- DNA packaging bias and differential expression of gene transfer agent genes within a population during production and release of the Rhodobacter capsulatus gene transfer agent, RcGTA. Molecular Microbiology. 85:314-325. 2012
- Characterization of a newly discovered Mu-like bacteriophage, RcapMu, in Rhodobacter capsulatus strain SB1003. Virology. 421:211-221. 2011
- Environmental, genomic and taxonomic perspectives on methanotrophic Verrucomicrobia. Environmental Microbiology Reports. 1:293-306. 2009
- Metabolomic Investigation of the Bacterial Response to a Metal Challenge. Applied and Environmental Microbiology. 75:719-728. 2009
-
preprints